Search

Your search keyword '"Bee Venoms pharmacology"' showing total 743 results

Search Constraints

Start Over You searched for: Descriptor "Bee Venoms pharmacology" Remove constraint Descriptor: "Bee Venoms pharmacology"
743 results on '"Bee Venoms pharmacology"'

Search Results

1. Study on the Effect of Bee Venom and Its Main Component Melittin in Delaying Skin Aging in Mice.

2. Evaluating the antibacterial efficacy of bee venom against multidrug-resistant pathogenic bacteria: Escherichia coli, Salmonella typhimurium, and Enterococcus faecalis.

3. Activation of mouse skin mast cells and cutaneous afferent C-fiber subtypes by bee venom.

4. Influence of Apis mellifera syriaca Bee Venom on Nociception and Inflammatory Cytokine Profiles in Experimental Hyperalgesia.

5. Influence of bee venom on antinociceptive activity of selected analgesic drugs in hot plate test in mice.

6. Cytotoxic effects of bee venom-loaded ZIF-8 nanoparticles on thyroid cancer cells: a promising strategy for targeted therapy.

7. A potential antifungal bioproduct for Microsporum canis: Bee venom.

8. Antimicrobial activities of seasonally collected bee products: honey, propolis, royal jelly, venom, and mellitin.

9. Bee venom and melittin: Potent key enzyme inhibitors with promising therapeutic potential.

10. Bee venom prompts the inhibition of gefitinib on proliferation, migration, and invasion of non-small cell lung cancer cells via EGFR-mediated autophagy.

11. Potential mitochondrial ROS-mediated damage induced by chitosan nanoparticles bee venom-loaded on cancer cell lines.

12. Anti-metastatic Effects of Bee Venom and Melittin in Breast Cancer Cells by Upregulation of BRMS1 and DRG1 Genes.

13. Melittin and phospholipase A2: Promising anti-cancer candidates from bee venom.

14. Bee venom as a promising therapeutic strategy in central nervous system diseases.

15. Effect of Apis mellifera syriaca Bee Venom on Glioblastoma Cancer: In Vitro and In Vivo Studies.

16. Exploring bee venom and silver nanoparticles for controlling foulbrood pathogen and enhancing lifespan of honeybees.

17. Ame-miR-1-3p of bee venom reduced cell viability through the AZIN1/OAZ1-ODC1-polyamines pathway and enhanced the defense ability of honeybee (Apis mellifera L.).

18. Bee venom enhances performance and immune function in thinlip mullet: A promising approach for sustainable aquaculture.

19. Targeted delivery of bee venom to A549 lung cancer cells by PEGylate liposomal formulation: an apoptotic investigation.

20. Potential therapeutic biomolecules of hymenopteran venom against SARS-CoV-2 from Egyptian patients.

21. Melittin-The principal toxin of honeybee venom-Is also produced in the honeybee fat body.

22. The PLA 2 inhibitor from Crotalus durissus terrificus blood plasma (CNF) inhibits group III-PLA 2 from honeybee venom.

23. Impact of bee venom supplement on productive performance, health status and economics of weaned male rabbits: Considering breed and dosage factors.

24. Immunomodulatory activities and biomedical applications of melittin and its recent advances.

25. Exploring the antibiofilm effects on Escherichia coli biofilm associated with colon cancer and anticancer activities on HCT116 cell line of bee products.

26. Bee Venom Stimulates Growth Factor Release from Adipose-Derived Stem Cells to Promote Hair Growth.

27. Efficacy of the bee-venom antimicrobial peptide Osmin against sensitive and carbapenem-resistant Klebsiella pneumoniae strains.

28. Impact of apitherapy on canine, equine, and chicken lymphocytes, in vitro.

29. The current landscape of the antimicrobial peptide melittin and its therapeutic potential.

30. Synergistic effects of bee venom, hesperidin, and piperine with tamoxifen on apoptotic and angiogenesis biomarker molecules against xerographic MCF-7 injected rats.

31. Bee Venom Toxic Effect on MDA-MB-231 Breast Cancer Cells and Caenorhabditis Elegans .

32. Mechanism underlying the anti-diabetic potential of bee venom as compared to bone marrow mesenchymal stem cells in the diabetic rat tongue.

33. Honeybee Venom: A Potential Source of Anticancer Components.

34. Investigation the effects of bee venom and H-dental-derived mesenchymal stem cells on non-small cell lung cancer cells (A549).

35. Effect of gamma-irradiated honey bee venom on blood parameter and histopathological observations of liver and kidney in a mice animal model.

36. Bee venom ameliorates oxidative stress and histopathological changes of hippocampus, liver and testis during status epileptics.

37. The effects of bee venom on behavior and the role of leptin in rats.

38. Bee venom (Apis mellifera L.) rescues zinc oxide nanoparticles induced neurobehavioral and neurotoxic impact via controlling neurofilament and GAP-43 in rat brain.

39. Chemical composition and antibacterial activity of bee venom against multi-drug resistant pathogens.

40. An Updated Review Summarizing the Anticancer Efficacy of Melittin from Bee Venom in Several Models of Human Cancers.

41. Bee Venom Induces the Interaction between Phosphorylated Histone Variant, H2AX, and the Intracellular Site of beta-Actin in Liver and Breast Cancer Cells.

42. Chemical Composition and Antimicrobial Properties of Honey Bee Venom.

43. Apitoxin alleviates methyl mercury-induced peripheral neurotoxicity in male rats by regulating dorsal root ganglia neuronal degeneration and oxidative stress.

44. Mellitin peptide quantification in seasonally collected crude bee venom and its anticancer effects on myelogenous K562 human leukaemia cell line.

45. Bee venom as an alternative for antibiotics against Staphylococcus aureus infections.

46. Beneficial Effect of Bee Venom and Its Major Components on Facial Nerve Injury Induced in Mice.

47. Identification of waprin and its microbicidal activity: A novel protein component of honeybee (Apis mellifera) venom.

48. The role of bee venom on immunological and hematological parameters in albino rats.

49. Determination of the Effects of Bee Venom on Triple Negative Breast Cancer Cells in Vitro.

50. Honey bee venom melittin increases the oxidant activity of cisplatin and kills human glioblastoma cells by stimulating the TRPM2 channel.

Catalog

Books, media, physical & digital resources